Literature DB >> 26868009

INTERNAL DOSES OF THREE PERSONS STAYING 110 KM SOUTH OF THE FUKUSHIMA DAIICHI NUCLEAR POWER STATION DURING THE ARRIVAL OF RADIOACTIVE PLUMES BASED ON DIRECT MEASUREMENTS.

Osamu Kurihara1, Takahiro Nakagawa2, Chie Takada2, Kotaro Tani3, Eunjoo Kim3, Takumaro Momose2.   

Abstract

The authors describe the results of direct measurements made on three persons who stayed in Tokai-mura, a village located ∼110 km south of the Fukushima Daiichi Nuclear Power Station (FDNPS), during the arrival of significant radioactive plumes released from the FDNPS as a consequence of the Tohoku earthquake/tsunami/FDNPS accident in March 2011. These measurements were made using a NaI(Tl) spectrometer and a whole-body counter shortly after the accident. Their thyroid equivalent doses ((131)I) were estimated to be 0.9-1.4 mSv under the assumption of acute intake via inhalation on 15 March, when the first significant release event was observed. Although greatly depending on the physicochemical form of iodine, the intake amount ratios of (131)I to (137)Cs for the three subjects were calculated as 2.7-3.7, which were much smaller than the radioactivity ratio (7.8) found in air sampling at the same site.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26868009     DOI: 10.1093/rpd/ncw002

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  1 in total

1.  Use of Iodine-131 to Tellurium-132 Ratios for Assessing the Relationships between Human Inhaled Radioactivity and Environmental Monitoring after the Accident in Fukushima.

Authors:  Koji Uchiyama; Masami Miyashita; Yoshinobu Tanishima; Shigenobu Maeda; Hitoshi Sato; Jun Yoshikawa; Shuji Watanabe; Masamichi Shibata; Shuji Ohhira; Gen Kobashi
Journal:  Int J Environ Res Public Health       Date:  2018-03-09       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.